The study does is a supportive and complementary method to clinical procedures and does not offer medical treatment (please see the project description).
Conditions
Interventions
Group 1: Intervention group (15 subjects/patients): VR intervention lasts approximately 9 minutes APAIS+STAI+HADS questionnaires
Group 2: Control group (15 subjects/patients)
Without VR intervention
A
Sponsors
Charité Universitätsmedizin Berlin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: – Adult patients (= 18 years of age) who are scheduled to be admitted to the intensive care unit. – Capacity to consent to participation in the study. – No previous ICU stays for the condition in question.
Exclusion criteria
Exclusion criteria: Presence of epilepsy or other disorders that could trigger seizures due to VR-visualized stimuli Previous intensive ICU stays in the patient concerned. Known presence of mental disorders that could be negatively affected by the study Participants who have already taken part in the PERISKOP study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in the APAIS total score between control and experimental group over time (difference in APAIS total score T1 to T2 or T3). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints: • Change in patient anxiety measured using the APAIS questionnaire (anxiety subscale) from T1 to T2 and T3 • Change in patient information satisfaction measured using the APAIS questionnaire (information subscale) from T1 to T2 and T3 • Change in anxiety/nervousness levels measured using the STAI questionnaire (state measurement) from T1 to T2 and T3 • Clinic-specific fears and associated depressive symptoms using the HADS (T3). • Qualitative evaluation of the video experience based on random patient interviews. | — |
Countries
Germany
Contacts
Public ContactZeynep Akbal
Charité Universitätsmedizin Berlin
Outcome results
None listed